Express News | Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering
Bluejay Diagnostics Shares Are Trading Lower After the Company Priced Its Public Offering.
Express News | Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering
US Futures Trend Lower Pre-Bell as Investors Await Slew of Economic Data
Bluejay Diagnostics Shares Are Trading Lower After the Company Announced SYMON-I Study Results. The Stock Initially Traded Higher, but It Has Since Reverse.
Bluejay Diagnostics Sees Positive Trial Results for Interleukin-6
Bluejay Diagnostics Announces SYMON-I Study Results; IL-6 Levels Within 24 Hours of ICU Admission Predict 28-Day Mortality in Sepsis and Septic Shock Patients; Findings to Be Validated in SYMON-II Study
SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients
Bluejay Diagnostics Files to Offer 2.9M Units, Each Consisting of One Share, Two Class C Warrants and One Class D Warrant
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Ovid Therapeutics OVID Phase 3 Failure; Bluejay Diagnostics BJDX Reverse Split
12 Health Care Stocks Moving In Monday's Pre-Market Session
Express News | Bluejay Announces 1-for-8 Reverse Stock Split
Express News | Bluejay Diagnostics Announces Reverse Stock Split
Bluejay Diagnostics | 10-Q: Quarterly report
12 Health Care Stocks Moving In Wednesday's After-Market Session
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Bluejay Diagnostics Announces CFO Change and Stockholders' Meeting Date
Bluejay Diagnostics Q4 EPS $(1.78) Misses $(0.68) Estimate
Bluejay Diagnostics Received Nasdaq Notification Letter Regarding Non-Compliance Under The Listing Rule; Deadline Until August 26, 2024, Extendable For An Additional 180 Days-8K
No Data